AI platform for early-stage lung cancer diagnosis and management
| Date | Round | Amount |
|---|---|---|
| Sep 2022 | Series A Optellum, an Oxford AI lung-cancer diagnosis medtech, raised $14M Series A led by Mercia. | $14M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.